Acute tongue and pharyngeal cramps when changing from clozapine to amisupride. A case study;Akute zungen-schlund-krampfe bei umstellung von clozapin auf amisulprid: Ein fallbeispiel

Nervenarzt

Volumn 71, Issue 11, 2000, Pages 919-922

  Jatzko, A ^a   Ries, S ^a   Schreiner, A ^a   Braus, D F ^a  

^a CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Amisulpride; Atypical antipsychotics; Clozapine; Receptor profiles; Switching

Indexed keywords

AMISULPRIDE; CLOZAPINE; DOPAMINE RECEPTOR; DRUG DERIVATIVE; NEUROLEPTIC AGENT; SULPIRIDE; SULTOPRIDE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COGNITION; DRUG MECHANISM; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HOSPITALIZATION; HUMAN; MUSCLE CRAMP; PHARYNX DISEASE; QUALITY OF LIFE; SCHIZOPHRENIA; SOCIAL INTERACTION; TONGUE DISEASE; TREATMENT OUTCOME; ACUTE DISEASE; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; DRUG COMBINATION; DRUG EFFECT; MUSCLE SPASM; PSYCHOLOGICAL ASPECT; PSYCHOSIS;

ACUTE DISEASE; ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; PHARYNGEAL DISEASES; PSYCHOTIC DISORDERS; RECEPTORS, DOPAMINE; SPASM; SULPIRIDE; TONGUE DISEASES;

EID: 0033732450     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150050685     Document Type: Article

References (34)

1. Do novel antipsychotics have similar pharmacological characteristics? A Review of the Evidence
2. Conversions from clozapine to other antipsychotic drugs
3. D2-dopamine rezeptor occupancy measured by IBZM-SPECT in relation to extrapyramidal side effects
4. Radioreceptor binding profile of the atypical antipsychotic olanzapine
5. Pet measurements of neuroreceptor occupancy by typical and atypical neuroleptics
6. Dopamine-cell depolarization block as a model for the therapeutic actions of antipsychotic drugs
7. Differential effects of repeated treatment with haloperidol and clozapine and dopamine release and metabolism in the striatum and the nucleus accumbens
8. 5-HT2 antagonism and EPS benefits - Is there a causal connection
9. Use of neuroleptic-induced extrapyramidal symptoms to predict future vulnerability to side effects
10. Persistence of haloperidol in human brain tissue
11. Mechanisms of action of atypical antipsychotic drugs - A critical analysis
12. Stationare und ambulante richtlinien zur umstellung von typischen neuroleptika auf atypische antipsychotika
13. Anticholinergics to treat clozapine withdrawl
14. Turnover rates of gamma-aminobutyric acid in substantia nigra, N. caudatus, globus pallidus and N. acumbens of rats injected with cataleptogenic and non-cataleptogenic antipsychotics
15. The mechanism of action of novel antipsychotic drugs
16. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, Risperidone and Conventional Antipsychotics
17. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia
18. D-1, D-2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration - Pet study of schizophrenic patients
19. Psychopharmacological profile of amisulpride: An antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity
20. A Dilemma Born of Progress: Switching from Clozapine to a Newer Antipsychotic
21. Prevalence of neuroleptic-induced dystonia in mania and schizophrenia
22. Neurochemical characteristics of amisulpricle, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity
23. Risperidone compared with new and reference antipsychotic drugs - In vitro and in vivo receptor binding
24. Dopamine receptor pharmacology
25. Rapid release of antipsychotic drugs from dopamine D2 receptor: An explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine
26. Cholonergic rebound and rapid onset psychosis following abrupt clozapine withdrawal
27. Antischizophrenic drugs and brain cholinergic receptors
28. The third dopamine receptor (D3) as a novel target for antipsychotics
29. Clozapine withdrawal resulting in delirium with psychosis: A report of three cases
30. Clozapine withdrawal effects and rezeptor profiles of typical and atypical neuroleptics
31. Switching antipsychotic medications
32. Prevention of acute dystonic reactions in patients beginning high-potency neuroleptics
33. Novel antipsychotics: Comparison of weight gain liabilities